Literature DB >> 33450472

Suicidal ideation during COVID-19 lockdown in Greece: Prevalence in the community, risk and protective factors.

Athanasia Papadopoulou1, Vasiliki Efstathiou2, Vasiliki Yotsidi3, Valeria Pomini4, Ioannis Michopoulos1, Evaggelia Markopoulou2, Marianna Papadopoulou5, Evdoxia Tsigkaropoulou1, Georgia Kalemi1, Kalliopi Tournikioti1, Athanasios Douzenis1, Rossetos Gournellis6.   

Abstract

The aim of this study was to investigate the prevalence of suicidal ideation in the community as well as the risk and protective factors of suicidal ideation during restriction measures in Greece, after the outbreak of the COVID-19 pandemic. Α web-based anonymous survey was conducted during the first lockdown period. Participants completed the Generalized Anxiety Disorder scale (GAD-2), the Patient Health Questionnaire (PHQ-2), the Systemic Clinical Outcome and Routine Evaluation (SCORE-15), the Connor-Davidson Resilience Scale (CD-RISK-2), and a self-report questionnaire for COVID-19 pandemic-related data. From a total of 5,116 adults included in the study, 5.20% reported suicidal thoughts, 14.17% were potential clinical cases of anxiety, and 26.51% of depression. Participants presented significantly higher suicidal ideation rates during the last two weeks of the lockdown compared to its previous two weeks. Unmarried or divorced marital status, mental health history, poor perceived quality of physical health, impaired family functioning, anxiety and depression symptoms were independently associated with higher odds of suicidal ideation, whereas higher resilience, positive feelings with regard to the lockdown measures, relationship with friends, and faith in a Supreme Being were associated with lower suicidal ideation odds. According to the findings, suicidal ideation prevalence might be considered elevated and its increase during the lockdown period alarming. The risk and protective factors identified in the study offer valuable information for the development of preventive strategies against suicidal ideation, especially in times of crisis.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  COVID-19; Depression; Greece; Online survey; Resilience; Suicidal ideation

Year:  2021        PMID: 33450472     DOI: 10.1016/j.psychres.2021.113713

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  12 in total

1.  A one-year longitudinal study on suicidal ideation, depression and anxiety during the COVID-19 pandemic.

Authors:  Vasiliki Efstathiou; Athanasia Papadopoulou; Valeria Pomini; Vasiliki Yotsidi; Georgia Kalemi; Katerina Chatzimichail; Ioannis Michopoulos; Adamantia Kaparoudaki; Marianna Papadopoulou; Nikolaos Smyrnis; Athanasios Douzenis; Rossetos Gournellis
Journal:  Asian J Psychiatr       Date:  2022-05-19

2.  Longitudinal associations between multiple mental health problems and suicidal ideation among university students during the COVID-19 pandemic.

Authors:  Zijuan Ma; Dongfang Wang; Jingbo Zhao; Yuanyuan Zhu; Yifan Zhang; Zihao Chen; Jiaqi Jiang; Ye Pan; Zheng Yang; Zhiyi Zhu; Xianchen Liu; Fang Fan
Journal:  J Affect Disord       Date:  2022-05-18       Impact factor: 6.533

3.  Prevalence of anxiety, depression, stress, and perceived stress and their relation with resilience during the COVID-19 pandemic, a cross-sectional study.

Authors:  Seyedeh Yasamin Parvar; Narges Ghamari; Fatemehsadat Pezeshkian; Reza Shahriarirad
Journal:  Health Sci Rep       Date:  2022-01-06

4.  Mental Health among Higher Education Students during the COVID-19 Pandemic: A Cross-Sectional Survey from Lithuania.

Authors:  Emilijus Žilinskas; Giedrė Žulpaitė; Kristijonas Puteikis; Rima Viliūnienė
Journal:  Int J Environ Res Public Health       Date:  2021-12-02       Impact factor: 3.390

Review 5.  Suicidality and COVID-19: Suicidal ideation, suicidal behaviors and completed suicides amidst the COVID-19 pandemic (Review).

Authors:  Vasiliki Efstathiou; Maria-Ioanna Stefanou; Nikolaos Siafakas; Michael Makris; Georgios Tsivgoulis; Vassilios Zoumpourlis; Demetrios A Spandidos; Nikolaos Smyrnis; Emmanouil Rizos
Journal:  Exp Ther Med       Date:  2021-12-02       Impact factor: 2.447

Review 6.  Mental Health Consequences of COVID-19 Pandemic Period in the European Population: An Institutional Challenge.

Authors:  Nicola Di Fazio; Donato Morena; Giuseppe Delogu; Gianpietro Volonnino; Federico Manetti; Martina Padovano; Matteo Scopetti; Paola Frati; Vittorio Fineschi
Journal:  Int J Environ Res Public Health       Date:  2022-07-30       Impact factor: 4.614

Review 7.  Ecosystem restoration is integral to humanity's recovery from COVID-19.

Authors:  Jake M Robinson; James Aronson; Christopher B Daniels; Neva Goodwin; Craig Liddicoat; Laura Orlando; David Phillips; Jessica Stanhope; Philip Weinstein; Adam T Cross; Martin F Breed
Journal:  Lancet Planet Health       Date:  2022-09

8.  Suicidality in psychiatric emergency department situations during the first and the second wave of COVID-19 pandemic.

Authors:  Yann David Kippe; Maia Adam; Anna Finck; James Kenneth Moran; Meryam Schouler-Ocak; Felix Bermpohl; Stefan Gutwinski; Thomas Goldschmidt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-07       Impact factor: 5.760

9.  Prevalence of suicidality in clinically stable patients with major depressive disorder during the COVID-19 pandemic.

Authors:  Ling Zhang; Hong Cai; Wei Bai; Si-Yun Zou; Ke-Xin Feng; Yu-Chen Li; Huan-Zhong Liu; Xiangdong Du; Zhen-Tao Zeng; Chang-Mou Lu; Lan Zhang; Wen-Fang Mi; Yan-Hong Ding; Juan-Juan Yang; Todd Jackson; Teris Cheung; Zhaohui Su; Feng-Rong An; Yu-Tao Xiang
Journal:  J Affect Disord       Date:  2022-03-22       Impact factor: 6.533

10.  Does suicidal ideation increase during the second COVID-19 lockdown?

Authors:  Vasiliki Efstathiou; Ioannis Michopoulos; Vasiliki Yotsidi; Nikolaos Smyrnis; Christina Zompola; Athanasia Papadopoulou; Valeria Pomini; Marianna Papadopoulou; Evdoxia Tsigkaropoulou; Georgios Tsivgoulis; Athanasios Douzenis; Rossetos Gournellis
Journal:  Psychiatry Res       Date:  2021-05-09       Impact factor: 11.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.